Education
About Us
Working with TipRanks
Follow Us
Medicinova (MNOV)
NASDAQ:MNOV
Total Valuation
Medicinova has a market cap or net worth of $71.37M. The enterprise value is $41.74M.
Market Cap$71.37M
Enterprise Value$41.74M
Share Statistics
Medicinova has 49,221,245 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,221,245
Owned by Insiders2.88%
Owned by Institutions2.53%
Financial Efficiency
Medicinova’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -31.63%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-31.63%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee31.51K
Profits Per Employee-922.92K
Employee Count13
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medicinova is ―. Medicinova’s PEG ratio is -1.23.
PE Ratio―
PS Ratio156.89
PB Ratio1.55
Price to Fair Value1.55
Price to FCF-6.55
Price to Operating Cash Flow-7.25
PEG Ratio-1.23
Income Statement
In the last 12 months, Medicinova had revenue of 409.66K and earned -12.00M in profits. Earnings per share was -0.24.
Revenue409.66K
Gross Profit31.05K
Operating Income-13.28M
Pretax Income-11.99M
Net Income-12.00M
EBITDA-11.97M
Earnings Per Share (EPS)-0.24
Cash Flow
In the last 12 months, operating cash flow was -9.81M and capital expenditures 0.00, giving a free cash flow of -9.81M billion.
Operating Cash Flow-9.81M
Free Cash Flow-9.81M
Free Cash Flow per Share-0.20
Dividends & Yields
Medicinova pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.22
52-Week Price Change-3.33%
50-Day Moving Average1.53
200-Day Moving Average1.39
Relative Strength Index (RSI)49.18
Average Volume (3m)1.79M
Important Dates
Medicinova upcoming earnings date is Apr 26, 2023, TBA (Confirmed).
Last Earnings DateJul 27, 2022
Next Earnings DateApr 26, 2023
Ex-Dividend Date―
Financial Position
Medicinova as a current ratio of 8.16, with Debt / Equity ratio of 0.47%
Current Ratio8.16
Quick Ratio8.16
Debt to Market Cap<0.01
Net Debt to EBITDA2.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medicinova has paid 5.99K in taxes.
Income Tax5.99K
Effective Tax Rate>-0.01
Enterprise Valuation
Medicinova EV to EBITDA ratio is -2.81, with an EV/FCF ratio of -3.43.
EV to Sales82.17
EV to EBITDA-2.81
EV to Free Cash Flow-3.43
EV to Operating Cash Flow-3.43
Balance Sheet
Medicinova has $30.81M in cash and marketable securities with $194.33K in debt, giving a net cash position of $30.61M billion.
Cash & Marketable Securities$30.81M
Total Debt$194.33K
Net Cash$30.61M
Net Cash Per Share$0.62
Tangible Book Value Per Share$0.65
Margins
Gross margin is 7.58%, with operating margin of -3242.47%, and net profit margin of -2928.78%.
Gross Margin7.58%
Operating Margin-3242.47%
Pretax Margin-2927.32%
Net Profit Margin-2928.78%
EBITDA Margin-2922.41%
EBIT Margin-2927.32%
Analyst Forecast
The average price target for Medicinova is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$11.00
Price Target Upside663.89% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―